{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:00:10Z","timestamp":1788548410262,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hrthm.2022.07.031","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T23:22:21Z","timestamp":1659828141000},"page":"1993-2001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4579-0216","authenticated-orcid":false,"given":"Michael R.","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan D.","family":"Aasbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marye J.","family":"Gleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley P.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio D.","family":"Schuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Brisben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhael F.","family":"El-Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2022.07.031_bib1","series-title":"Rhythm Management Product Performance Report","author":"Naughton","year":"2021"},{"key":"10.1016\/j.hrthm.2022.07.031_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2022.07.031_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jce.13498","article-title":"Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: long-term complications, replacements, and battery longevity","volume":"29","author":"Quast","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2022.07.031_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2022.07.031_bib7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.jacep.2020.05.036","article-title":"1-Year prospective evaluation of clinical outcomes and shocks: the Subcutaneous ICD Post Approval Study","volume":"6","author":"Burke","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.07.031_bib10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"380","author":"Tarakji","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2022.07.031_bib11","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jacc.2019.09.060","article-title":"Risk factors for infections involving cardiac implanted electronic devices","volume":"74","author":"Birnie","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.hrthm.2021.04.014","article-title":"Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients","volume":"18","author":"El-Chami","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"17","author":"Polyzos","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2022.07.031_bib14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/europace\/euab028","article-title":"Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score","volume":"23","author":"Ahmed","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2022.07.031_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacep.2021.08.009","article-title":"Risk factors for CIED infection after secondary procedures: insights from the WRAP-IT trial","volume":"8","author":"Tarakji","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/eurheartj\/ehz316","article-title":"Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018)","volume":"40","author":"Olsen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.07.031_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous Implantable Cardioverter-Defibrillator Post-Approval Study: clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2019.04.048","article-title":"Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): clinical characteristics and perioperative results","volume":"16","author":"Boersma","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib19","series-title":"An Introduction to the Bootstrap,","volume":"57","author":"Efron","year":"1993"},{"key":"10.1016\/j.hrthm.2022.07.031_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/hrt.2008.151985","article-title":"Risk factors and time delay associated with cardiac device infections: Leiden device registry","volume":"95","author":"Lekkerkerker","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2022.07.031_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007691","article-title":"Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads","volume":"7","author":"Koneru","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2022.07.031_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","article-title":"Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction","volume":"13","author":"Boersma","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/eurheartj\/ehq497","article-title":"Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients","volume":"32","author":"Johansen","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.07.031_bib25","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2022.07.031_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib27","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/jce.15080","article-title":"Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: subcutaneous versus transvenous implantable defibrillator therapy","volume":"32","author":"Palmisano","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib28","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11886-018-1021-8","article-title":"An overview of clinical outcomes in transvenous and subcutaneous ICD patients","volume":"20","author":"Baalman","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hrthm.2022.07.031_bib30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies","volume":"3","author":"Basu-Ray","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.07.031_bib31","article-title":"Efficacy, safety, and in-hospital outcomes of subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis and systematic review","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.hrthm.2022.07.031_bib32","article-title":"Late-breaking randomized clinical trials LB-733-01: Subcutaneous Versus Transvenous Defibrillators: The ATLAS Trial","volume":"19","author":"Healey","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.hrthm.2020.02.011","article-title":"The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: long-term follow-up","volume":"17","author":"Mittal","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2022.07.031_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euab019","article-title":"Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations","volume":"23","author":"Callahan","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2022.07.031_bib35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/euu147","article-title":"Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival","volume":"16","author":"Tarakji","year":"2014","journal-title":"Europace"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527122022780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527122022780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:16:36Z","timestamp":1716426996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527122022780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1547527122022780"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2022.07.031","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2022.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}